Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?

Radical cystectomy (RC) is the standard of care treatment of localized muscle-invasive bladder cancer (BC). However, about 50% of patients develop metastases within 2 years after cystectomy. Neoadjuvant cisplatin-based chemotherapy before cystectomy improves the overall survival (OS) in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wezel, Felix, Vallo, Stefan, Roghmann, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760384/
https://www.ncbi.nlm.nih.gov/pubmed/29354494
http://dx.doi.org/10.21037/tau.2017.09.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760384/
https://www.ncbi.nlm.nih.gov/pubmed/29354494
http://dx.doi.org/10.21037/tau.2017.09.18

Ejemplares similares